| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.097 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.074 | 0.3 |